{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:03:12Z","timestamp":1759104192946,"version":"3.44.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.jneuroim.2008.06.010","type":"journal-article","created":{"date-parts":[[2008,7,23]],"date-time":"2008-07-23T04:19:31Z","timestamp":1216786771000},"page":"41-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Complementary strategies to elucidate T helper cell epitopes in myasthenia gravis"],"prefix":"10.1016","volume":"201-202","author":[{"given":"Christine","family":"Jung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Stoeckle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Heinz","family":"Wiesm\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00fcdiger","family":"Laub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Emmrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnther","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Melms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2008.06.010_bib1","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1212\/WNL.44.9.1732","article-title":"Treatment of myasthenia gravis with anti-CD4 antibody: improvement correlates to decreased T-cell autoreactivity","volume":"44","author":"Ahlberg","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.06.010_bib2","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1172\/JCI119760","article-title":"HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis","volume":"100","author":"Bradley","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jneuroim.2003.11.022","article-title":"Different patterns of nicotinic acetylcholine receptor subunit transcription in human thymus","volume":"149","author":"Bruno","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib4","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: past, present, and future","volume":"116","author":"Conti-Fine","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0198-8859(99)00135-4","article-title":"Complementation between specific HLA-DR and HLA-DQ genes in transgenic mice determines susceptibility to experimental autoimmune encephalomyelitis","volume":"61","author":"Das","year":"2000","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1006\/smim.1999.0198","article-title":"Quantitative analysis of peptide-MHC class II interaction","volume":"11","author":"Fleckenstein","year":"1999","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jneuroim.2004.03.019","article-title":"Lack of pathogenicity of immunodominant T and B cell determinants of the nicotinic acetylcholine receptor epsilon-chain","volume":"152","author":"Gaertner","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0167-5699(96)10022-0","article-title":"Autoimmune T cells in myasthenia gravis: heterogeneity and potential for specific immunotargeting","volume":"17","author":"Hawke","year":"1996","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jneuroim.2008.06.010_bib9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199902)45:2<224::AID-ANA13>3.0.CO;2-B","article-title":"Early-onset myasthenia gravis: a recurring T-cell epitope in the adult-specific acetylcholine receptor epsilon subunit presented by the susceptibility allele HLA-DR52a","volume":"45","author":"Hill","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0960-5428(94)00040-U","article-title":"The role of the thymus in myasthenia gravis","volume":"4","author":"Hohlfeld","year":"1994","journal-title":"Adv. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/310244a0","article-title":"Autoimmune human T lymphocytes specific for acetylcholine receptor","volume":"310","author":"Hohlfeld","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2008.06.010_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-1759(98)00139-2","article-title":"New ligands for HLA DRB1\u204e0301 by random selection of favourable amino acids ranked by competition studies with undecapeptide amide sublibraries","volume":"219","author":"Jung","year":"1998","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jneuroim.2008.06.010_bib13","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.4049\/jimmunol.152.6.3152","article-title":"Major histocompatibility complex class II gene disruption prevents experimental autoimmune myasthenia gravis","volume":"152","author":"Kaul","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-1759(00)00288-X","article-title":"A multiple transgenic mouse model with a partially humanized activation pathway for helper T cell responses","volume":"246","author":"Laub","year":"2000","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jneuroim.2008.06.010_bib15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1749-6632.1998.tb10954.x","article-title":"Muscle nicotinic acetylcholine receptor mRNA expression in hyperplastic and neoplastic myasthenia gravis thymus","volume":"841","author":"MacLennan","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/15525","article-title":"A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor","volume":"23","author":"Madsen","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib17","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/intimm\/5.10.1229","article-title":"Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis","volume":"5","author":"Malcherek","year":"1993","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib18","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4049\/jimmunol.153.3.1141","article-title":"Analysis of allele-specific contact sites of natural HLA-DR17 ligands","volume":"153","author":"Malcherek","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib19","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/(SICI)1521-4141(199805)28:05<1524::AID-IMMU1524>3.0.CO;2-T","article-title":"MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation","volume":"28","author":"Malcherek","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib20","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.4049\/jimmunol.155.7.3683","article-title":"Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor","volume":"155","author":"Matsuo","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib21","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1172\/JCI113401","article-title":"Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients","volume":"81","author":"Melms","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/ana.410310314","article-title":"T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: heterogeneity of antigenic sites on the alpha-subunit","volume":"31","author":"Melms","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.it.2005.05.007","article-title":"Understanding crypticity is the key to revealing the pathogenesis of autoimmunity","volume":"26","author":"Moudgil","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib24","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.4049\/jimmunol.162.7.4079","article-title":"Scanning a DRB3\u204e0101 (DR52a)-restricted epitope cross-presented by DR3: overlapping natural and artificial determinants in the human acetylcholine receptor","volume":"162","author":"Nagvekar","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/1097-4598(200102)24:2<203::AID-MUS50>3.0.CO;2-F","article-title":"Human thymuses express incomplete sets of muscle acetylcholine receptor subunit transcripts that seldom include the delta subunit","volume":"24","author":"Navaneetham","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2008.06.010_bib26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-065X.1999.tb01398.x","article-title":"The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases","volume":"167","author":"Price","year":"1999","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0167-5699(93)90237-F","article-title":"Myasthenia gravis: recognition of a human autoantigen at the molecular level","volume":"14","author":"Protti","year":"1993","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jneuroim.2008.06.010_bib28","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ana.410290510","article-title":"Acetylcholine receptor-specific T-lymphocyte clones in the normal human immune repertoire: target epitopes, HLA restriction, and membrane phenotypes","volume":"29","author":"Salvetti","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib29","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/WNL.41.8.1270","article-title":"Acetylcholine receptor-reactive T lymphocytes from healthy subjects and myasthenia gravis patients","volume":"41","author":"Sommer","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.06.010_bib30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-065X.1998.tb01215.x","article-title":"Identification of autoantigen epitopes in MHC class II transgenic mice","volume":"164","author":"Sonderstrup","year":"1998","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib31","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1172\/JCI200318028","article-title":"Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis","volume":"112","author":"Tolosa","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0022-1759(93)90124-P","article-title":"A europium fluoroimmunoassay for measuring binding of antigen to class II MHC glycoproteins","volume":"163","author":"Tompkins","year":"1993","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jneuroim.2008.06.010_bib33","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.humimm.2007.05.009","article-title":"Polymorphisms in the cathepsin L2 (CTSL2) gene show association with type 1 diabetes and early-onset myasthenia gravis","volume":"68","author":"Viken","year":"2007","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.0105-2896.2005.00317.x","article-title":"Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces","volume":"207","author":"Villadangos","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib35","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","article-title":"Unravelling the pathogenesis of myasthenia gravis","volume":"2","author":"Vincent","year":"2002","journal-title":"Nat. Rev., Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib36","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1212\/WNL.33.10.1276","article-title":"Acetylcholine receptor antibody and clinical response to thymectomy in myasthenia gravis","volume":"33","author":"Vincent","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.06.010_bib37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-065X.1998.tb01217.x","article-title":"Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis","volume":"164","author":"Vincent","year":"1998","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib38","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.4049\/jimmunol.157.8.3752","article-title":"Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis","volume":"157","author":"Wakkach","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.2003.tb06028.x","article-title":"Creation versus destruction of T cell epitopes in the class II MHC pathway","volume":"987","author":"Watts","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib40","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1749-6632.1981.tb33753.x","article-title":"Thymic myogenesis, T-lymphocytes and the pathogenesis of myasthenia gravis","volume":"377","author":"Wekerle","year":"1981","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib41","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI14255","article-title":"Mapping myasthenia gravis-associated T cell epitopes on human acetylcholine receptors in HLA transgenic mice","volume":"109","author":"Yang","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2008.06.010_bib42","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.4049\/jimmunol.174.3.1729","article-title":"Cathepsin S is required for murine autoimmune myasthenia gravis pathogenesis","volume":"174","author":"Yang","year":"2005","journal-title":"J. Immunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557280800204X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557280800204X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:10:00Z","timestamp":1759047000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557280800204X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":42,"alternative-id":["S016557280800204X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.06.010","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complementary strategies to elucidate T helper cell epitopes in myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}